Sanofi: Company Financial Information
 Company name  Sanofi    ISIN:  FR0000120578
 End of Fiscal Year:  December 31 2015    Founded Year:  1999

Sanofi

(at previous day's close)
Market Cap. 96,673.79 m
Shares In Issue 1,285.04 m
Prev. Close 74.25
PE Ratio 22.64  
Dividend Yield 3.95 %
EPS – basic 3.28 c
Dividend PS 2.93 c
Dividend Cover 1.12
Cash Flow PS 6.94 c
Return On Equity (ROE) 7.73 %
Operating Margin - %
PEG Factor -  
EPS Growth Rate - %
Dividend PS Growth Rate 2.81 %
Net Debt 34,852.00 m
Gross Gearing 43.11 %
Quick Assets 12,311.00 m
Net Working Cap 85,496.00 m
Intangibles / Fixed Assets 11.02 %
Turnover PS 26.88 c
Pre-Tax Profit PS 0.00 c
Retained Profit PS - c
Cash PS 720.52 c
Net Cash PS -588.77 c
Net Tangible Asset Value PS* 364.27 c
Net Asset Value PS 7,962.46 c
Spread 0.01 (0.01%)
*Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Sanofi Balance Sheet (Dec 31 2015)

SAN:liab eqSAN:assets

Sanofi Share Price

Sample Period † High Low
1 week 73.06 77.26
4 weeks 73.06 79.04
12 weeks 71.74 79.50
1 year 71.74 80.28

Sanofi (5 years)

Sanofi Historic Returns

Period *  Open Change % Open Avg. Avg. Daily Vol [m] Total Vol. [m] VWAP
1 week 77.26 -2.03 -2.63 74.19 2,180,947.00 74.17
4 weeks 78.12 -2.89 -3.70 76.38 2,244,744.00 76.42
12 weeks 74.66 0.57 0.76 75.62 2,430,665.00 75.79
26 weeks 74.12 1.11 1.50 75.77 2,377,916.00 75.78
1 year 71.95 3.28 4.56 75.74 2,410,115.00 75.80
3 years 75.41 -0.18 -0.24 75.75 2,462,765.00 75.37
5 years 75.50 -0.27 -0.36 78.28 2,758,044.00 78.31
* periods calculated are whole weeks rather than calendar months

Sanofi Key Management Ratio

Sanofi Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio 15.40  
PE Ratio 22.64  
Tobin's Q Ratio 0.94  
Tobin's Q Ratio (excl. intangibles) 1.91  
Dividend Yield 3.95 %
Market-to-Book Ratio 0.93  
Price-to-Pre-Tax Profit PS 181,984.44  
Price-to-Retained Profit PS -  
Price-to-Cash Flow PS 10.70  
Price-to-Sales PS 2.76  
Price-to-Net Tangible Asset Value PS 0.20  
Price-to-Cash PS 0.10  
Net Working Capital PS 66.53  
Price Pct to Working Capital PS 1.12 %
Earnings Yield 0.04 %
Average PE -  
Years in Average PE -  
PE to PE average - %

Sanofi Financial Ratios

(Leverage Ratios)
Debt Ratio 79.01 %
Debt-to-Equity Ratio 0.60  
Debt-to-Equity Ratio (excl. Intgbl) 5.26  
Debt-to-Equity Market Value 0.36  
Net Gearing 34.06 %
Net Gearing (excl. Intangibles) 68.69 %
Gross Gearing 43.11 %
Gross Gearing (excl. Intangibles) 86.94 %
Gearing Under 1 Year 16.44 %
Gearing Under 1 Year (excl. Intgbl) 33.16 %
Assets / Equity 1.76  
Cash / Equity 0.16  
(Liquidity Ratios)
Net Working Capital to Total Assets 83.56 %
Current Ratio 2.19  
Quick Ratio (Acid Test) 1.80  
Liquidity Ratio 0.55  
Cash & Equiv / Current Assets 25.16 %
(Solvency Ratios)
Enterprise Value 1,147,007.85 m
Sales 0.26  
CFO / Attributable Profit -  
CFO / Assets 0.00  
CFO / Debt 0.00  
Total Debt / Equity Market Value 0.46  
Total Debt / Sales 1.28  
Total Debt / Pre-Tax Profit 8,413,312.99  
Total Debt 44,111.00 m
Total Debt / Net Current Assets 0.52 %
(Dodds – Graham Ratios)
3 yr Compound Earnings Growth - %
5 yr Compound Earnings Growth - %
10 yr Compound Earnings Growth - %
Earn drops > 5% in 10yrs 10.00  
Beta (60-Mnth) Beta (36-Mnth)
- -
Alpha (60-Mnth) Alpha (36-Mnth)
- -

Sanofi Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE) 0.00 %
Return On Assets (ROA) - %
Net Profit Margin - %
Assets Turnover 0.00  
Return On Equity (ROE) 7.73 %
Return On Investment (ROI) - %
Dividend Payout Ratio 89.33 %
Plowback Ratio 10.67 %
Growth from Plowback Ratio 82.45 %
Net Income of Revenues - %
(Asset Utilisation Multiples)
Shareholders Equity Turnover 0.00  
Fixed Assets Turnover 0.00  
Current Assets Turnover 0.00  
Net Working Capital Turnover 0.00  
Inventory Turnover 0.00  
(Other Operating Ratios)
Total Assets-to-Sales 2.96  
Debtors-to-Sales 25.63 %
Debt Collection Period 93.55 Days

Sanofi Dividends

Type Curr. Dividend Amount Period Start Period End Total Dividend Amount
Final EUR 2.93 Dec 31 2014 Dec 31 2015 2.93
Final EUR 2.85 Dec 31 2013 Dec 31 2014 2.85
Final EUR 2.80 Dec 31 2012 Dec 31 2013 2.80
Final EUR 2.77 Dec 31 2011 Dec 31 2012 2.77
Final EUR 2.65 Dec 31 2010 Dec 31 2011 2.65
Final EUR 2.50 Dec 31 2009 Dec 31 2010 2.50
Final EUR 2.40 Dec 31 2008 Dec 31 2009 2.40
Final EUR 2.20 Dec 31 2007 Dec 31 2008 2.20

Sanofi Fundamentals
  Dec 31 2012 (EUR) Dec 31 2013 (EUR) Dec 31 2014 (EUR) Dec 31 2015 (EUR)
Turnover 34,947.00 100.00% 32,951.00 100.00% 33,770.00 100.00% 34,542.00 100.00% m
Pre Tax Profit 5,877.00 16.82% 4,603.00 13.97% 5,731.00 16.97% 5,243.00 15.18% m
Attributable Profit - -% - -% - -% - -% m
Retained Profit - -% - -% - -% - -% m
Eps – Basic 3.76 2.81 3.34 3.28
Eps – Diluted 3.74 2.78 3.30 3.25
Dividends per Share 2.77 2.80 2.85 2.93

Sanofi Balance Sheet

  Dec 31 2012 (EUR) Dec 31 2013 (EUR) Dec 31 2014 (EUR) Dec 31 2015 (EUR)
SAN:liab eqSAN:assets SAN:liab eqSAN:assets SAN:liab eqSAN:assets SAN:liab eqSAN:assets
  Dec 31 2012 (EUR) Dec 31 2013 (EUR) Dec 31 2014 (EUR) Dec 31 2015 (EUR)
ASSETS
fixed assets  Fixed assets - -% - -% - -% - -% m
intangibles  Intangibles 58,265.00 58.03% 52,529.00 54.68% 53,740.00 55.18% 51,583.00 50.41% m
fixed investments  Fixed Investments 3,585.00 3.57% 4,583.00 4.77% 4,189.00 4.30% 4,681.00 4.57% m
current assets - other  Current Assets – Other 16,015.00 15.95% 15,305.00 15.93% 16,332.00 16.77% 21,429.00 20.94% m
stocks  Stocks 6,379.00 6.35% 6,352.00 6.61% 6,562.00 6.74% 6,516.00 6.37% m
debtors  Debtors 9,604.00 9.57% 8,854.00 9.22% 9,010.00 9.25% 8,853.00 8.65% m
cash & securities  Cash & securities 6,559.00 6.53% 8,442.00 8.79% 7,559.00 7.76% 9,259.00 9.05% m
Other assets 107.00 0.11% 29.00 0.03% 69.00 0.07% 5,801.00 5.67% m
TOTAL 100,407.00 100.00% 96,065.00 100.00% 97,392.00 100.00% 102,321.00 100.00% m
LIABILITIES
creditors - short  Creditors – Short 13,860.00 24.12% 13,957.00 24.48% 13,032.00 23.16% 16,825.00 28.90% m
creditors - long  Creditors – Long 29,075.00 50.59% 25,094.00 44.01% 28,092.00 49.93% 27,286.00 46.88% m
TOTAL 42,935.00 74.71% 39,051.00 68.49% 41,124.00 73.09% 44,111.00 75.78% m
EQUITY
Minority Interest -57,338.00 -99.77% -56,885.00 -99.77% -56,120.00 -99.74% -58,049.00 -99.72% m
Capital Reserves 57,338.00 99.77% 56,885.00 99.77% 56,120.00 99.74% 58,049.00 99.72% m
TOTAL 57,472.00 100.00% 57,014.00 100.00% 56,268.00 100.00% 58,210.00 100.00% m

Sanofi Cash Flow Statement

Dec 31 2012 (EUR) Dec 31 2013 (EUR) Dec 31 2014 (EUR) Dec 31 2015 (EUR)
Operating CF 8,171.00 6,954.00 7,690.00 8,920.00
Investing CF -1,587.00 -1,273.00 -3,458.00 -3,265.00
Financial CF -4,351.00 -3,726.00 -5,182.00 -3,593.00
Net change CF 2,233.00 1,955.00 -950.00 2,062.00

Sanofi Employee Data

Dec 31 2012 (EUR) Dec 31 2013 (EUR) Dec 31 2014 (EUR) Dec 31 2015 (EUR)
Number of employees 112,128.00 112,128.00 113,496.00 115,631.00
Sales per employee 0.31 0.29 0.30 0.30 m

Data supplied by
Your Recent History
EU
SAN
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:fm D:20190718 12:25:49